A Prospective Study on Optimizing Treatment for ABPA

Clinical trial NCT05129033 · UNKNOWN

Trial details

NCT number: NCT05129033
Sponsor: Shanghai Zhongshan Hospital
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Allergic Bronchopulmonary Aspergillosis

Start date: 2021-11-15
Primary completion: 2023-06-30
Enrollment: 100

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.